Verify that patients have reached an appropriate maintenance dose (5, 10, or 15 mg weekly, as tolerated) per FDA labeling
Esta experta seala que esos pacientes merecen acceso a tratamiento junto con prevencin y apoyo, y aadi que los sistemas de salud tambin deben abordar la imagen de los medicamentos como una especie de solucin cosmtica y fcil
Key micronutrients to monitor
Sleep Tight: Climb into bed, pull up your lightweight sheets, and let the cool air work its magic
Others find that protein-focused meals cause less nausea than carbohydrate-heavy options
The most common cabozantinib-associated adverse events (all grades) included diarrhea (63.1%), palmar-plantar erythrodysesthesia (50%), decreased weight (47.7%), decreased appetite (45.8%), nausea (43%), and fatigue (40.7%) Grade 3 or 4 adverse events were reported in 69% of patients in the cabozantinib group and 33% of patients in the placebo group